CVRx offers a heart failure therapy option with Barostim™, the world’s first neuromodulation device for heart failure management. The therapy is designed to improve symptoms of heart failure and enhance patients' quality of life by delivering gentle electrical pulses to baroreceptors, helping regulate the body's cardiovascular response.
Barostim has been shown to safely improve heart failure symptoms, increase activity levels, and provide significant improvement in quality of life for patients who do not respond adequately to medications alone. The implant procedure typically takes about an hour, and most patients go home the same day.
